@id-kieran.bsky.social
Mortality and Causes of Death in Patients with Mycobacterium avium Complex Isolates through 28 years
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Mortality and Causes of Death in Patients with Mycobacterium avium Complex Isolates through 28 years
This nationwide study of 2,027 Danish patients with MAC isolates (1991-2018) revealed declining mortality. Age, male sex, DMAC, and comorbidities were asso
bit.ly
November 10, 2025 at 3:04 PM
New strategies for a vexing problem: injectables to the rescue for people with Multidrug-Resistant HIV
✅ Just Accepted
🔗 https://bit.ly/4ovrYCU
✅ Just Accepted
🔗 https://bit.ly/4ovrYCU
November 10, 2025 at 3:04 PM
Closing the Gap in Race-based Inequities for Seasonal Influenza Hospitalizations: A Modeling Study
#IDSky
#IDSky
Closing the Gap in Race-based Inequities for Seasonal Influenza Hospitalizations: A Modeling Study
We use a mathematical model incorporating racial inequities in the United States to determine the effects of interventions aimed at ameliorating inequity i
bit.ly
November 4, 2025 at 3:08 AM
Impact of discontinuation of contact precautions on healthcare-associated ESBL-producing Escherichia coli in a large tertiary care hospital: an interrupted time-series analysis
✅ Just Accepted
🔗 https://bit.ly/47t7eEk
✅ Just Accepted
🔗 https://bit.ly/47t7eEk
November 4, 2025 at 3:07 AM
Distinct defects in marginal zone B cells and filtration function characterize hyposplenism in persons with HIV on prolonged ART
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3LasAPr
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3LasAPr
October 27, 2025 at 1:40 PM
IDSA cUTI *with* sepsis:
“This recommendation places a higher value on providing early, appropriate empiric antibiotic therapy to prevent mortality while deferring stewardship considerations to definitive therapy.” #IDSky
Rec empiric Rx:
- 3 or 4th gen cephalosporins
- carbapenems
- pip-tazo
- FLQ
“This recommendation places a higher value on providing early, appropriate empiric antibiotic therapy to prevent mortality while deferring stewardship considerations to definitive therapy.” #IDSky
Rec empiric Rx:
- 3 or 4th gen cephalosporins
- carbapenems
- pip-tazo
- FLQ
October 27, 2025 at 1:39 PM
COVID-19 Vaccine Effectiveness in Patients with Hematologic Malignancies: a Nationwide Cohort Study
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4nZcC9q
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4nZcC9q
October 20, 2025 at 8:26 PM
Carbapenem-resistant Organisms in Companion Animals in New York City, 2019?2022
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Carbapenem-resistant Organisms in Companion Animals in New York City, 2019–2022
Abstract. Carbapenem-resistant organisms (CRO) are a type of antibiotic-resistant bacteria that threaten human health. CRO can infect or colonize dogs and
bit.ly
October 20, 2025 at 8:25 PM
Noninferiority Study of Purified Vero Rabies Vaccine—Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines
#IDSky
#IDSky
Validate UserNoninferiority Study of Purified Vero Rabies Vaccine—Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines
A next-generation, serum-free, highly purified Vero cell rabies vaccine, PVRV-NG2, is in development.
bit.ly
October 14, 2025 at 1:19 PM
Exploring the interaction between injection site and biological sex on the real-world population pharmacokinetics of long acting cabotegravir and rilpirivine in people living with HIV
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4obm2ya
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4obm2ya
October 14, 2025 at 1:19 PM
Clinical and laboratory features of hemophagocytic lymphohistiocytosis in people with disseminated histoplasmosis
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4mWe2A4
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4mWe2A4
October 12, 2025 at 6:08 PM
Cefiderocol is noninferior to standard of care empiric treatment of noscomial Gram-negative bloodstream infections in open-label "Game-Changer" trial. #IDsky #Medsky
Cefiderocol is Noninferior, But not "Game-Changer," for Gram-negative Bloodstream Infections | Contagion Live
Cefiderocol is noninferior to standard of care empiric treatment of noscomial Gram-negative bloodstream infections in open-label "Game-Changer" trial.
www.contagionlive.com
October 12, 2025 at 6:08 PM
Reposted
Cefiderocol is noninferior to standard of care empiric treatment of noscomial Gram-negative bloodstream infections in open-label "Game-Changer" trial. #IDsky #Medsky
Cefiderocol is Noninferior, But not "Game-Changer," for Gram-negative Bloodstream Infections | Contagion Live
Cefiderocol is noninferior to standard of care empiric treatment of noscomial Gram-negative bloodstream infections in open-label "Game-Changer" trial.
www.contagionlive.com
October 12, 2025 at 12:41 PM
Dr. Jacinda Abdul-Mutakabbir describes the university's atmosphere, students' involvement in community-based care, and the support they receive. @jaycdoesid.bsky.social @ucsdmedschool.bsky.social #IDsky #Medsky
UC San Diego: Student Support, Academic Rigor, and Extensive Real-World Clinical Experience
Jacinda Abdul-Mutakabbir, PharmD, MPH, describes the university's atmosphere, students' involvement in community-based care, and the support they receive.
www.contagionlive.com
September 30, 2025 at 5:48 PM
Xpert MTB/RIF® cycle threshold as a marker of TB disease severity; Implications for TB treatment stratification
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3WbLI1G
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3WbLI1G
September 30, 2025 at 5:48 PM
Impact of Puberty on Immune Responses to Mycobacterium tuberculosis in South African Adolescents
#IDSky
#IDSky
Impact of Puberty on Immune Responses to Mycobacterium tuberculosis in South African Adolescents
IL-1ra, IP-10, and SAP are higher in adolescents with tuberculosis than healthy controls.Adrenal and adipose-derived hormones are higher and metabolic horm
bit.ly
September 22, 2025 at 3:44 PM
⭐New Publication⭐
Published in the October 2025 issue of Clinical Nutrition "Serum Galectin-9 and Decorin in relation to brain aging and the green-Mediterranean diet: A secondary analysis of the DIRECT PLUS randomized trial."
➡️ Read here: www.sciencedirect.com/science/arti...
Published in the October 2025 issue of Clinical Nutrition "Serum Galectin-9 and Decorin in relation to brain aging and the green-Mediterranean diet: A secondary analysis of the DIRECT PLUS randomized trial."
➡️ Read here: www.sciencedirect.com/science/arti...
September 22, 2025 at 3:43 PM
CSF immune cell alterations in women with neuropsychiatric Long COVID
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3JY7PGe
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3JY7PGe
September 16, 2025 at 2:30 PM
Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, offers some insights on the latest diagnostics, susceptibility testing for newer antimicrobials, and how infectious disease clinicians and laboratory professionals can collaborate in case management to collaborate on challenging cases.
Adoption of Rapid Diagnostic Tools, Susceptibility Testing for Gram-Negative Infections
Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, offers some insights on the latest diagnostics, susceptibility testing for newer antimicrobials, and how infectious disease clinicians and laboratory pro...
www.contagionlive.com
September 16, 2025 at 2:29 PM
Cost-effectiveness of alternative approaches to hepatitis C diagnosis and treatment initiation for treatment-naive people who inject drugs in Australia: a model-based economic evaluation
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Cost-effectiveness of alternative approaches to hepatitis C diagnosis and treatment initiation for treatment-naive people who inject drugs in Australia: a model-based economic evaluation
AbstractBackground. Eliminating hepatitis C virus (HCV) requires efficient testing and treatment strategies. We evaluated cost-effectiveness of alternative...
doi.org
September 8, 2025 at 5:19 PM
In CID, Maria Ines Figueroa and colleagues evaluated the antiviral activity of dolutegravir/lamivudine among antiretroviral therapy (ART)-naive patients with HIV with a CD4 count ≤200 cells/mm³. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf415/8241230
September 8, 2025 at 5:19 PM
Azelastine nasal spray showed promise in a phase 2 trial - patients using it had fewer SARS-CoV-2 infections (2.2% vs 6.7%), longer time to infection, and reduced symptomatic cases. Larger studies are needed to confirm. #COVID19 #IDsky #MEDsky
More details: www.contagionlive.com/view/azelast...
More details: www.contagionlive.com/view/azelast...
September 8, 2025 at 5:19 PM
🚨 Ebola Outbreak in Kasai Province, DRC. 28 suspected cases and 15 deaths, including 4 health-care workers, have been reported. Africa CDC & the WHO are mobilizing rapid response teams, vaccines, & supplies to contain the outbreak. #IDsky #MEDsky
More details: www.contagionlive.com/view/ebola-o...
More details: www.contagionlive.com/view/ebola-o...
September 8, 2025 at 5:18 PM
Reposted
🚨 Ebola Outbreak in Kasai Province, DRC. 28 suspected cases and 15 deaths, including 4 health-care workers, have been reported. Africa CDC & the WHO are mobilizing rapid response teams, vaccines, & supplies to contain the outbreak. #IDsky #MEDsky
More details: www.contagionlive.com/view/ebola-o...
More details: www.contagionlive.com/view/ebola-o...
September 8, 2025 at 4:26 PM
🚨 Ebola Outbreak in Kasai Province, DRC. 28 suspected cases and 15 deaths, including 4 health-care workers, have been reported. Africa CDC & the WHO are mobilizing rapid response teams, vaccines, & supplies to contain the outbreak. #IDsky #MEDsky
More details: www.contagionlive.com/view/ebola-o...
More details: www.contagionlive.com/view/ebola-o...
Azelastine nasal spray showed promise in a phase 2 trial - patients using it had fewer SARS-CoV-2 infections (2.2% vs 6.7%), longer time to infection, and reduced symptomatic cases. Larger studies are needed to confirm. #COVID19 #IDsky #MEDsky
More details: www.contagionlive.com/view/azelast...
More details: www.contagionlive.com/view/azelast...
Azelastine Nasal Spray Reduces SARS-CoV-2 Infections in Phase 2 Trial
Single-center randomized trial shows lower infection rates and extended time to SARS-CoV-2 infection, though larger studies are needed to confirm findings.
www.contagionlive.com
September 4, 2025 at 5:11 PM